Active Ingredient History
Gadobutrol (INN) (Gd-DO3A-butrol) is a gadolinium-based MRI contrast agent (GBCA). Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arthritis, Rheumatoid (Phase 1)
Body Image (Phase 4)
Brain Diseases (Phase 4)
Brain Neoplasms (Phase 4)
Breast Diseases (Phase 4)
Breast Neoplasms (Phase 3)
Carotid Stenosis (Phase 3)
Central Nervous System Diseases (Phase 3)
Cognition (Phase 4)
Contrast Media (Phase 4)
Coronary Artery Disease (Phase 3)
Diagnostic Imaging (Phase 3)
Fibrosis (Phase 4)
Genital Neoplasms, Female (Phase 1)
Glioma (Early Phase 1)
Heart Failure (Phase 1)
Kidney Failure, Chronic (Phase 4)
Lymphoma (Early Phase 1)
Magnetic Resonance Imaging (Phase 4)
Motor Activity (Phase 4)
Multiple Sclerosis (Phase 4)
Myocardial Perfusion Imaging (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 4)
Peripheral Arterial Disease (Phase 4)
Prostatic Neoplasms (Phase 3)
Renal Artery Obstruction (Phase 3)
Spinal Cord Diseases (Phase 2)
Urinary Bladder Neoplasms (Early Phase 1)
Uterine Cervical Neoplasms (Phase 1)
Vascular Diseases (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
